Patent · US Active

Anti-HLA-G antibodies, compositions comprising anti-HLA-G antibodies and methods of using anti-HLA-G antibodies

US12264199B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

Tizona Therapeutics · US

Inventors

Courtney Beers · Seattle, US
John Corbin · Oakland, US
Doug Hodges · South San Francisco, US
Achim Moesta · South San Francisco, US
Vanessa Soros · South San Francisco, US
Paul Fredrick Widboom · Lebanon, US
Joseph Robert Warfield · South San Francisco, US

Key dates

Filing date	Nov 18, 2021
Grant date	Apr 1, 2025
Priority date	—
Expiry date	Sep 18, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are antibodies that selectively bind to HLA-G and and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.